Bangladesh has launched an independent national review of its Expanded Programme on Immunization and vaccine-preventable disease surveillance system, with WHO support, following a measles outbreak that exposed continuing immunity gaps.
The review will run from 4 to 14 October and cover all eight divisions of the country. Teams will assess programme management and financing, staffing, vaccine supply and cold-chain systems, service delivery, coverage and safety monitoring, disease surveillance, outbreak preparedness and public communication.
Bangladesh has remained polio-free for more than 15 years, sustained elimination of maternal and neonatal tetanus, controlled rubella and introduced additional vaccines. WHO said the 2026 measles outbreak nevertheless demonstrated vulnerabilities that require closer examination.
WHO Representative to Bangladesh Dr Ahmed Jamsheed Mohamed said: “Bangladesh has a long and proud history of protecting its children through immunization.”
Findings and recommendations are expected to be presented on 14 October, followed by a draft report and action plan in November.
